Are you Dr. McCormack?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
323 S 18th Ave
Sturgeon Bay, WI 54235Phone+1 920-743-5566Fax+1 414-290-6755
Summary
- Dr. Francis McCormack, MD is an emergency medicine physician in Sturgeon Bay, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Illinois. He is affiliated with Door County Medical Center.
Education & Training
Loyola Medicine MacNeal HospitalResidency, Family Medicine, 1987 - 1990
University of Illinois College of MedicineClass of 1987
Certifications & Licensure
WI State Medical License 2004 - 2025
IL State Medical License 1987 - 2011- American Board of Family Medicine Family Medicine
Publications & Presentations
PubMed
- 11 citationsThe vitamin D binding protein axis modifies disease severity in lymphangioleiomyomatosis.Suzanne Miller, Clare Coveney, Janice Johnson, Aliki-Eleni Farmaki, Nishant Gupta
The European Respiratory Journal. 2018-11-01 - 9 citationsSmoking-Related Diffuse Cystic Lung Disease.Nishant Gupta, Thomas V. Colby, Cristopher A. Meyer, Francis X. McCormack, Kathryn A. Wikenheiser-Brokamp
Chest. 2018-08-01 - 126 citationsLymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official A...Nishant Gupta, Geraldine A. Finlay, Robert M. Kotloff, Charlie Strange, Kevin C. Wilson
American Journal of Respiratory and Critical Care Medicine. 2017-11-15
Grant Support
- 2012 International LAM Research ConferenceNational Heart, Lung, And Blood Institute2012
- 2011 International LAM Research ConferenceNational Heart, Lung, And Blood Institute2011
- 2010 Nhlbi/Lam Foundation International Lymphangioleiomyomatosis Research ConfereNational Heart, Lung, And Blood Institute2010
- 2009 LAM Foundation International Research ConferenceNational Heart, Lung, And Blood Institute2009
- Phase III Trial FO Sirolimus In LymphangioleiomylmatosisFood And Drug Administration2007–2009
- 2008 LAM Foundation International Research ConferenceNational Heart, Lung, And Blood Institute2008
- Clinical Trial: Sirolimus Multicenter International Lymphangioleiomomatosis TriaNational Center For Research Resources2008
- The 2007 LAM Foundation Lymphangioleiomyomatosis International Research ConferencNational Heart, Lung, And Blood Institute2007
- Lymphangioleiomyomatosis Research Conference 2006National Heart, Lung, And Blood Institute2006
- Novel Antioxidant Mechanisms Of Surfactant ProteinsNational Heart, Lung, And Blood Institute2002–2006
- 2005 LAM Foundation Lymphangioleiomyomatosis ResearchNational Heart, Lung, And Blood Institute2005
- Lymphangioleimyomatosis Research ConferenceNational Heart, Lung, And Blood Institute2004
- Lymphangioleiomyomatosis Research ProjectNational Heart, Lung, And Blood Institute2003
- Lymphangioleiomyomatosis Research ProjectNational Heart, Lung, And Blood Institute2002
- Surfactant Protein A In Pulmonary Host DefenseNational Heart, Lung, And Blood Institute1999–2002
- Lymphangioleiomyomatosis Research ConferenceNational Heart, Lung, And Blood Institute2001
- Structure/Function Relationships Of Surfactant Protein ANational Heart, Lung, And Blood Institute1994
- Structure/Function Relationships Of Surfactant Protein ANational Heart, Lung, And Blood Institute1990–1994
